Andrew J. Greenfield

2021

In 2021, Andrew J. Greenfield earned a total compensation of $4M as Executive Vice President and Chief Commercial Officer at ABIOMED, a 43% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$328,095
Option Awards$377,276
Salary$301,454
Stock Awards$3,010,116
Other$9,126
Total$4,026,067

Greenfield received $3M in stock awards, accounting for 75% of the total pay in 2021.

Greenfield also received $328.1K in non-equity incentive plan, $377.3K in option awards, $301.5K in salary and $9.1K in other compensation.

Rankings

In 2021, Andrew J. Greenfield's compensation ranked 3,330th out of 12,415 executives tracked by ExecPay. In other words, Greenfield earned more than 73.2% of executives.

ClassificationRankingPercentile
All
3,330
out of 12,415
73rd
Division
Manufacturing
1,355
out of 5,505
75th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
164
out of 801
80th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
107
out of 522
80th
Industry
Surgical and Medical Instruments and Apparatus
71
out of 327
78th
Source: SEC filing on June 28, 2022.

Greenfield's colleagues

We found four more compensation records of executives who worked with Andrew J. Greenfield at ABIOMED in 2021.

2021

Michael Minogue

ABIOMED

Chief Executive Officer

2021

Todd Trapp

ABIOMED

Chief Financial Officer

2021

Marc Began

ABIOMED

General Counsel

2021

David Weber

ABIOMED

Chief Operating Officer

News

You may also like